, Public institutions or public/private partnerships could for example issue non-exclusive or free licences on their patents, 18 U.S.C. Section, vol.203, issue.1, p.38, 2001.
, Suwit Wibulpolprasert said that the avian flu virus and vaccine issue had become very sensitive?. He said that even in a normal situation like the present, countries like Brazil and Thailand that make use of the flexibilities in the WTO's TRIPS agreement were facing pressures that they had never experienced before.In a pandemic situation, the countries' use of such flexibilities in relation to intellectual property should not be questioned at all, he said, By Martin Khor, 2007.
, If compulsory licencing is automatically allowed, countries would be enabled to make the vaccines, « India stated that in an emergency, countries should be able to make vaccines, regardless of who holds the patent, 2007.
, Les politiques de santé au Brésil. Technologie, industrie, Etat et Santé publique, vol.27, 2009.
, Developing Countries, Donor Leverage, and access to Bird Flu Vaccines, vol.41, pp.1-9, 2007.
, Strategies for containing an emerging influenza pandemic in Southeast Asia, 2005.
, Nature, vol.436, p.7051
, on the use of antiviral drugs against the H1N1 flue also makes no mention of the question of generics. It is limited to the constitution of an emergency stock provided by donors. 67 "Renforcer la coopération multilatérale en matière de propriété intellectuelle et de santé publique, p.14, 2009.
, OMS, 2009.
, Networks of innovation. Vaccine Development at Merck, Sharp and Dohme, and Mulford, pp.1895-1995, 1995.
, Economics of AIDS and access to HIV/AIDS care in developing countries, ANRS Collection 'Sciences sociales et sida', 2003.
URL : https://hal.archives-ouvertes.fr/halshs-00112023
, Some IP Issues related to H5N1 Influenza Viruses, Research and Vaccines, Third World Network, vol.21, 2007.